Role of an e-Health Intervention in Holistic Healthcare: A Quasiexperiment in Patients Undergoing Cardiac Catheterization in Taiwan
Table 1
Characteristics of the patients at baseline.
Characteristics
Intervention (n = 150)
Control (n = 150)
All cases (n = 300)
value
Age (years)
62.85 ± 9.84
65.56 ± 10.15
64.2 ± 10.07
0.019
BMI (kg/m2)
27.22 ± 4.36
27.13 ± 4.77
27.18 ± 4.57
0.873
Male sex (n, %)
126 (84)
114 (76)
240 (80)
0.083
Smoking (n, %)
50 (33.3)
30 (20)
80 (26.7)
0.08
Medical history (n, %)
Diabetes mellitus
72 (48)
73 (48.7)
145 (48.3)
0.908
Hyperlipidemia
74 (49.3)
66 (44)
140 (46.7)
0.355
Heart failure
16 (10.7)
24 (16)
40 (13.3)
0.174
Stroke
7 (4.7)
10 (6.7)
17 (5.7)
0.454
Peripheral artery disease
1 (0.7)
4 (2.7)
5 (1.7)
0.176
COPD
2 (1.3)
5 (3.3)
7 (2.3)
0.251
Revascularization therapy (n, %)
Percutaneous coronary intervention
68 (45.3)
70 (46.7)
138 (46)
0.817
Coronary artery bypass grafting
6 (4)
2 (1.3)
8 (2.7)
0.152
Length of hospital stay (days)
3.54 ± 2.55
4.89 ± 5.07
4.22 ± 4.07
0.004
Coronary artery disease medication (n, %)
Antiplatelet
139 (92.7)
139 (92.7)
278 (92.7)
0.833
ACEI/ARB
90 (60.4)
83 (55.3)
173 (57.7)
0.375
Beta-blocker
107 (73.2)
114 (76)
223 (74.6)
0.572
Mineralocorticoid receptor antagonist
9 (6)
10 (6.7)
19 (6.3)
0.824
Statin
118 (79.2)
117 (78)
235 (78.3)
0.801
Nitrate
46 (30.9)
60 (40)
106 (35.3)
0.099
BMI, body mass index; COPD, chronic obstructive pulmonary disease; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin-receptor blockers. Data are presented as mean ± standard deviation or frequency and percentage in parenthesis.
